Seattle Genetics. Tnc.
1Patents
1Active
1Granted
38Portfolio score
Filing activity: Jun 1, 2017 → Jun 1, 2017
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US11299543B2 | Use of an anti-PD-1 antibody in combination with an anti-CD30 antibody in cancer treatment | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.